TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 92 filers reported holding TG THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 6.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $4,504,000 | -39.0% | 968,608 | +1.5% | 0.00% | 0.0% |
| Q3 2016 | $7,384,000 | +35.4% | 953,952 | +6.0% | 0.00% | 0.0% |
| Q2 2016 | $5,452,000 | -31.0% | 899,739 | -2.9% | 0.00% | 0.0% |
| Q1 2016 | $7,896,000 | -26.2% | 926,707 | +3.3% | 0.00% | -50.0% |
| Q4 2015 | $10,699,000 | +22.3% | 896,809 | +3.3% | 0.00% | 0.0% |
| Q3 2015 | $8,750,000 | -29.0% | 868,096 | +16.8% | 0.00% | 0.0% |
| Q2 2015 | $12,328,000 | +8.6% | 743,106 | +1.3% | 0.00% | 0.0% |
| Q1 2015 | $11,356,000 | +39.4% | 733,602 | +42.6% | 0.00% | +100.0% |
| Q4 2014 | $8,149,000 | +238.3% | 514,441 | +127.9% | 0.00% | – |
| Q3 2014 | $2,409,000 | +5.1% | 225,742 | -7.6% | 0.00% | – |
| Q2 2014 | $2,293,000 | +98.4% | 244,195 | +45.7% | 0.00% | – |
| Q1 2014 | $1,156,000 | +116.1% | 167,583 | +22.1% | 0.00% | – |
| Q4 2013 | $535,000 | -35.0% | 137,263 | -15.9% | 0.00% | – |
| Q3 2013 | $823,000 | +2.9% | 163,232 | +30.4% | 0.00% | – |
| Q2 2013 | $800,000 | – | 125,194 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 726,200 | $3,086,000 | 3.46% |
| Paradigm Biocapital Advisors LP | 1,964,709 | $8,350,000 | 1.66% |
| 683 Capital Management, LLC | 3,300,000 | $14,025,000 | 0.99% |
| MAVERICK CAPITAL LTD | 6,747,549 | $28,677,000 | 0.71% |
| Antara Capital LP | 1,500,000 | $6,375,000 | 0.27% |
| Parkwood LLC | 47,168 | $1,375,000 | 0.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,677,500 | $11,379,000 | 0.24% |
| PURA VIDA INVESTMENTS, LLC | 950,813 | $4,041,000 | 0.24% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 567,576 | $2,412,000 | 0.20% |
| Antara Capital LP | 900,000 | $3,825,000 | 0.16% |